Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) was delayed until March 21, 2025. Additional time is needed for review; therefore, the delay is extended for an additional 60 days.
Published
Mar 25, 2025
Effective
Dec 26, 2024
Citation
90 FR 13553
Agencies
2
Full text not available in our database.
View on Federal Register →Get a plain-English explanation of what this regulation does, which agencies are responsible, and how it affects existing rules.
No document text available yet
Docket No. FDA-2021-N-0862
0910-AH62
21 CFR 201
21 CFR 314